Paracil

Quick links to important sections

Paracil

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Paracil

Property Description
Active ingredient Paracetamol, Light Liquid Paraffin, White Soft Paraffin
Form Semisolid Preparation (Ointment/Emulsion)
Pharmacological Class Combined Analgesic, Antipyretic, and Emollient
Common Purpose Pain management, fever reduction, and skin protection
Origin Synthetic and Derived Mineral

1. Defining Paracil: Classification and Drug Type

Paracil is a combined drug product categorized as a blended analgesic, antipyretic, and emollient preparation. This formulation is typically presented as a semisolid preparation, such as an ointment or emulsion, which is designed for simultaneous support of systemic discomfort and the skin's external condition. Its unique identity arises from its capacity for both topical application and potential systemic absorption of the pain-relieving component, distinguishing it from products with a single route of administration. This combined classification is clinically recognized for addressing symptoms that require both internal soothing and external physical protection.

2. Paracil’s Core Composition: Synthetic and Mineral Components

The formulation of Paracil is precisely built upon two distinct material groups: the non-opioid analgesic Paracetamol (Acetaminophen) and the Derived Mineral agents, Light Liquid Paraffin and White Soft Paraffin. The primary active component, Paracetamol, is widely used for pain relief and fever reduction. The paraffins, which are refined hydrocarbons, constitute the occlusive agent base or vehicle. Paraffin-based emollients help to treat dry skin conditions by smoothing and softening the skin surface. This strategic combination of a systemic active ingredient with a topical protectant base is a differentiating feature, setting it apart from formulations that treat only one set of symptoms.

3. General Therapeutic Purpose of the Combined Formulation

The overall therapeutic goal of the combined Paracil formulation is to offer integrated symptomatic relief from both systemic discomfort and external skin issues. It generally helps in providing pain management and fever reduction through the action of the Paracetamol component. Concurrently, the emollient base supports skin conditioning, specifically aiming for epidermal barrier function restoration by physically preventing excessive Transepidermal Water Loss (TEWL). A typical scenario for its use is providing relief when fever or mild pain co-occurs with dry skin or localized irritation. This dual-purpose design means the medicine supports the patient by addressing both internal symptoms and external concerns within a single compound formulation.

Regulatory References

  1. EMA's Role and Responsibilities
  2. MHRA Drug Safety Update on Emollients

What side effects are possible with Paracil?

Possible side effects and safety information

Paracil is a combined formulation; its safety profile reflects the documented risks of both the systemic analgesic (Paracetamol) and the topical Paraffin base.

Adverse reactions are officially classified by frequency and system-organ class. At standard therapeutic doses, Paracetamol-related side effects are generally classified as rare or very rare. These effects primarily involve Immune System Disorders (hypersensitivity reactions, including rash) and, less frequently, Blood and Lymphatic System Disorders (changes in blood cell counts).

Local skin reactions, such as pruritus or a burning sensation at the application site, are documented for the paraffin component. These topical effects are also typically classified as rare in regulatory documents.


Serious Adverse Reactions and Safety Constraints

The most serious documented risk associated with Paracetamol is potentially fatal liver damage (hepatotoxicity), which is primarily observed in cases of overdose or in individuals with pre-existing risk factors. Regulatory agencies explicitly document the rare occurrence of severe skin reactions, including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).

Official safety notes advise caution for specific groups, particularly those with hepatic or renal impairment, and those with a history of chronic alcohol consumption, as these factors can increase the risk of hepatotoxicity. Furthermore, concomitant use with other Paracetamol-containing products is strictly restricted due to the serious risk of overdose.

A unique safety constraint for the paraffin base is the documented serious fire hazard; fabric (such as clothing or bedding) that has been in contact with the product can ignite more easily. Symptoms of Paracetamol-related liver damage may be delayed, sometimes appearing 12 to 48 hours after ingestion.

Overdose and Emergency Response

Overdose and when to seek help

The primary concern in Paracil overdose is the documented systemic toxicity of the Paracetamol component. This toxicity may lead to severe, delayed organ damage, even if the patient initially feels well.

Documented Overdose Manifestations

Early signs of overdose can be non-specific, often including nausea, vomiting, pallor, and abdominal pain. It is critically important to note that the patient may be asymptomatic during the first 24 hours, which does not rule out the development of life-threatening injury.

Severe Outcomes and Required Actions

The most severe documented outcomes involve progressive hepatic necrosis leading to acute liver failure, encephalopathy, coma, and potentially death. Acute renal failure and metabolic acidosis are also documented complications.

Immediate medical management is required in the event of any suspected overdose. Urgent assistance must be sought, and the patient must be referred to a hospital immediately. This is mandated because treatment with the specific antidote, N-acetylcysteine (NAC), is most effective when administered quickly. Hospital monitoring is required, including measurement of plasma Paracetamol concentration and liver enzyme levels. Individuals with chronic alcoholism or severe malnutrition are documented as having an elevated risk of severe toxicity.

Therapeutic Uses of Paracil

What Paracil Treats: Main Uses and Benefits

Paracil is considered relevant for addressing symptoms related to both internal systemic discomfort and external skin issues. The active analgesic component is commonly used to help with temporarily easing pain and temporarily managing fever, which supports the handling of distressing manifestations.

This combined preparation may be part of symptomatic management within clinical settings that involve acute or disruptive symptom patterns, and is commonly used during phases when symptoms become more noticeable. It supports the handling of distressing manifestations such as headache, muscular aches, and feverishness co-occurring with dry skin or skin irritation. The formulation is primarily relevant for easing discomfort linked to mild to moderate pain and addressing symptoms related to epidermal dryness.


“This formulation is commonly used across conditions presenting with acute episodes where additional management of discomfort for both systemic and external symptoms is needed.”


Quick Fact: Relief for Combined Symptoms

Component Symptom Domain Benefit
Systemic Active Mild to Moderate Pain, Fever Supports general well-being during symptomatic phases.
Emollient Base Dry Skin, Scaling Supports patients during difficult episodes by easing distress.

Key Therapeutic Domains

Paracil is commonly used to provide symptomatic assistance for systemic discomfort (pain and fever) associated with conditions like colds, flu, and everyday episodic pain. The emollient component further supports the patient by addressing dry skin conditions, scaling, and roughness, providing supportive relief when symptoms interfere with routine activities. This integrated support may assist with easing the overall symptom load of these combined manifestations.

Eligibility and Restrictions for Use

The official regulatory profile for Paracil strictly defines population eligibility, outlining groups that are prohibited from use, those requiring conditional use, and age-related constraints.

Prohibited Populations (Contraindications)

Use is absolutely contraindicated for patients with known hypersensitivity (allergy) to Paracetamol, Paraffins, or any formulation excipients. The medicine must not be used by individuals with severe hepatic dysfunction or active liver disease.

Conditional Use Populations (Caution Required)

Eligibility becomes restricted for patients with compromised organ function; this includes individuals with severe renal insufficiency or hepatocellular insufficiency. Caution is also mandated for individuals with risk factors such as chronic alcoholism or chronic malnutrition. The emollient component must not be applied to infected or weeping skin lesions.

Age and Physiological Eligibility

Paracil is generally permitted for use in adults and children. However, use is not established in preterm newborn infants, and the emollient base's safety and efficacy are not established in children under three years. For pregnant individuals, use is permitted only when clinically necessary and restricted to the lowest effective dose for the shortest duration. Use is generally permitted during breastfeeding.

What should I know about interactions with other medicines?

Paracil Interactions with other medicines and products

The interaction profile of Paracil is defined by the systemic activity of its Paracetamol component and the physical properties of its emollient base. A contraindicated combination is any other medicinal product containing Paracetamol, which is strictly prohibited to prevent exceeding the maximum dose and mitigate toxicity risk.

Pharmacokinetic interactions formally documented in regulatory sources modify the systemic exposure to Paracetamol. Metoclopramide or Domperidone are documented to increase the rate of absorption, while Cholestyramine reduces both the rate and extent of absorption, necessitating a mandatory one-hour separation between administrations. Co-administration with certain CYP enzyme inducers (such as Carbamazepine or Phenytoin) is stated to reduce Paracetamol concentration while increasing the risk of toxic metabolite formation. Furthermore, co-use with Zidovudine may reduce its clearance.

A pharmacodynamic interaction exists with oral anticoagulants (e.g., Warfarin), where co-administration formally increases the anticoagulant effect, requiring close monitoring. Specific restrictions apply to substances: chronic, excessive alcohol use is officially documented to increase the risk of Paracetamol-induced hepatotoxicity. Finally, the occlusive paraffin base requires physical separation in time or site from the application of other topical medicines to maintain their efficacy. This systemic and physical interaction structure requires careful regulatory consideration.

Mechanism of Action

The mechanism of Paracil relies on two distinct and complementary physiological processes: central chemical modulation and topical physical occlusion.

Central Modulation of Thermoregulation and Nociception

The active component interacts primarily within the Central Nervous System (CNS) to modulate pathways governing nociception and thermoregulation. This mechanism involves the inhibition of central Cyclooxygenase (COX) enzymes, particularly in the hypothalamus, which reduces the production of Prostaglandin E2 ( PGE2). This chemical cascade leads to a physiological reduction of the elevated thermoregulatory set point. Concurrently, a metabolite acts as an agonist at TRPV1 and CB1 receptors in the spinal cord, potentiating the body's own descending inhibitory pathways, which contributes to the modulation of pain signal transmission. The central focus of this mechanism results in constrained peripheral anti-inflammatory activity.

Physical Occlusion of the Epidermal Barrier

The emollient components (paraffins) exert a non-chemical, physical mechanism by forming an inert, hydrophobic occlusive layer on the skin's surface (Stratum Corneum). This barrier dramatically reduces the evaporation of water vapor—known as Transepidermal Water Loss (TEWL). By reducing TEWL, the mechanism increases the water content within the Stratum Corneum, modulating the physical characteristics of the external barrier. This physical occlusion mechanism is mechanistically independent of the systemic central action.

Dosage and Administration Information

Administration Route and Form

Paracil is administered exclusively through the Cutaneous (Topical) route as a semisolid emulsion. The medicine is not intended for ingestion. Application should be performed on the skin surface. The formulation combines the systemic analgesic with emollient agents, and the administration protocol is designed to regulate both functions.


Standard Dosing and Frequency

The standard procedure requires applying a Thin Layer of the emulsion directly to the affected skin area, gently rubbing it in until the product is fully absorbed. This application can be repeated up to Four Times Daily or As Needed for Skin Comfort to maintain the integrity of the occlusive barrier. If an application is missed, it should be applied when remembered, unless it is close to the next scheduled dose, in which case a double amount must not be used.


Procedural and Time Constraints

Official instructions differentiate usage duration: the product is indicated for Short-Term Use when addressing acute systemic symptoms. Conversely, the emollient component may be used Intermittently as part of a longer-term plan. A critical regulatory constraint mandates that the total quantity applied over 24 hours must not allow the Paracetamol component to exceed the established maximum systemic limit of 4000 mg per day. Furthermore, application is restricted only to Unbroken Skin to prevent excessive systemic absorption. Patients with Hepatic Impairment are subject to a reduction in this maximum total daily dose.

Recent Clinical Evidence

Research evidence / Overview of studies for Paracil

Evidence for the Systemic Management of Acute Mild-to-Moderate Pain

The systemic component of Paracil (Paracetamol) was evaluated in research exploring outcomes related to acute, short-term physical discomfort, such as headache, dental pain, and discomfort following minor surgery. The core evidence for this purpose comes from short-term Randomized Controlled Trials (RCTs). Research examined outcomes related to physical discomfort, often measuring the intensity of pain using standard scales and monitoring the need for rescue medication.

Studies conducted during periods of increased symptom activity describe patterns of symptom changes observed in the populations over the first few hours after a single dose. This evidence contributes to the broader research landscape for exploring changes in physical discomfort. Evidence is limited regarding the component's evaluation in many chronic pain conditions; research indicates that evidence remains insufficient or inconsistent for long-term use in these contexts.


Evidence for the Systemic Management of Feverishness

The research base for the component's use in temporary physiological imbalance (fever) has been evaluated in numerous clinical settings. RCTs are the primary study type, often applied in studies examining outcomes related to systemic or functional imbalance. Researchers examined outcomes related to temperature changes, measuring how quickly and to what extent an elevated body temperature was observed to change. A significant portion of this research was studied for use in pediatric populations (children), helping contextualize how temperature changes across different age groups.


Evidence for Epidermal Barrier Support

The research exploring the skin-supporting component of Paracil (paraffin emollients) was evaluated in dermatological studies focused on conditions associated with acute or disruptive episodes of dry skin. Research examined outcomes linked to the skin's physical function, such as objective measurements like Transepidermal Water Loss (TEWL) and skin hydration levels. Findings describe patterns observed in the studies that the occlusive base creates a physical layer on the skin, which is observed to affect TEWL.


What Remains Uncertain About Paracil's Evidence

The primary evidence gap is the lack of integrated clinical trials for the specific combined Paracil formulation. No dedicated RCTs specifically address the integrated use of the single preparation in settings where both systemic discomfort and external skin issues are present. Consequently, the overall understanding of this compound formulation is inferred from the established research on the individual systemic and topical components alone. Comparative evidence is lacking regarding the patient experience using this combination versus alternative approaches for similar combined symptom profiles.

Key Studies & References

  1. Acetaminophen (Tylenol, others)
  2. World Health Organization Model List of Essential Medicines (Relevant Sections on Analgesics/Antipyretics)

Frequently Asked Questions (FAQ)

Common questions about Paracil (FAQ)


Q: How quickly does Paracil start to work?

A: Regulatory documents for the systemic component (Paracetamol) administered orally indicate that the highest concentration in the bloodstream typically occurs within 30 to 60 minutes. The specific time of action for a topical emulsion can vary due to the way it is absorbed through the skin. Studies of the topical formulation noted that outcomes related to systemic effect were typically examined over the first few hours after application.


Q: How long does the effect of Paracil last?

A: The elimination half-life for the systemic component (Paracetamol) is stated in regulatory documents to vary from one to three hours. The official product instructions advise that the product can be applied up to four times daily. This official guidance for repeat application up to four times daily reflects how the duration of effect is considered within dosing protocols.


Q: Are generic versions of Paracil as effective as the brand name?

A: Regulatory authorities (e.g., the FDA) conduct evaluations to determine if a generic formulation is considered therapeutically equivalent to the corresponding brand name product. Generic medicines are required by regulators to contain the same active ingredient and be identical in strength and route of administration. They are reviewed to ensure they work in the same way as the brand name product before being approved as therapeutically equivalent.


Q: Is Paracil habit-forming or addictive?

A: Official information classifies the systemic component, Paracetamol, as a non-opioid analgesic. Regulatory documents describing its known actions do not include properties that are associated with habit-formation or addiction.


Q: Are there any warnings about driving or operating machinery while using Paracil?

A: Regulatory documents for the systemic component generally state that, when used at recommended amounts, it has no or negligible influence on a person’s ability to drive and operate machinery. This information is conditional on the user not experiencing any documented side effects that could affect their attention or motor skills.


Q: What if I take too much Paracil accidentally?

A: Official safety warnings emphasize that taking too much Paracetamol, which can be absorbed systemically from the topical product, may result in severe liver damage (hepatotoxicity). This damage may be delayed, sometimes appearing 12 to 48 hours later. Official sources document that immediate medical assessment is necessary in the event of suspected overdose, even if a person feels well, due to the serious risks involved.


Q: Is Paracil the same as other pain relievers I can buy?

A: Paracil is officially described as a unique combined drug product. It contains a non-opioid analgesic (Paracetamol) and a topical emollient base. This specific formulation is administered only through the cutaneous (skin) route, which differentiates it from many common pain relievers that are intended to be swallowed.


Q: What happens if I forget to use a dose of Paracil?

A: Official instructions describe the procedure for a missed application, which generally involves applying the product when remembered, unless it is close to the next scheduled time. Instructions strictly prohibit using a double amount to make up for a missed application.


Q: What should I do if a side effect of Paracil seems bad?

A: Regulatory documents list serious adverse effects, and official safety notes emphasize that medical assessment is necessary if any serious reaction, such as a spreading skin rash, swelling, or severe abdominal pain, is experienced.


Q: Is there a different name for Paracil in other countries?

A: The systemic active component in Paracil is known by different names internationally. Regulatory and official sources confirm this component is commonly referred to as Paracetamol in many countries, and as Acetaminophen in the United States.


Q: What type of medicine is Paracil classified as?

A: Official documentation classifies Paracil as a combined drug product. It falls into the pharmacological class of a blended analgesic, antipyretic, and emollient preparation, designed for systemic discomfort relief and topical skin support.


Q: Is it normal to feel tired after taking Paracil?

A: Regulatory documents listing the adverse effects for Paracetamol-containing products do not typically include drowsiness or fatigue as a common side effect. By modulating symptoms such as pain or fever, relief may lead to physical comfort.


Q: Does Paracil have a taste or smell?

A: Paracil is a semisolid emulsion intended for application on the skin only, and is not for ingestion. The formulation contains mineral paraffins, which typically possess minimal to no sensory characteristics, but any slight taste or smell would depend on the specific inactive ingredients used.


Q: Are there specific foods I should avoid while using Paracil?

A: Regulatory documents explicitly mention that chronic, excessive alcohol use increases the risk of serious liver damage from the Paracetamol component. Official regulatory sources generally do not list specific foods or non-alcoholic drinks as substances to avoid due to interaction risks.


Q: Why do some people say Paracil helps with tension headaches?

A: The systemic component of Paracil (Paracetamol) is widely known and officially indicated in regulatory documents for the temporary management of acute, mild-to-moderate physical discomfort. This scope of use includes conditions such as headache.


Q: What is the main difference between Paracil and Drug-X (a similar OTC pain reliever)?

A: Paracil is fundamentally distinguished by its dual composition and route of administration. It is a topical product with a systemic analgesic component and a skin-protecting emollient base. This contrasts with many other common pain relievers which are typically designed as single-component products taken orally.


Q: What is the maximum number of days I can use Paracil?

A: Regulatory instructions define the product for short-term use when addressing acute systemic symptoms. While the maximum dose limit for the systemic component is known, the specific maximum duration for all potential indications is typically determined by national regulatory guidance and the clinical context of use (such as acute or intermittent application).


Q: Does Paracil come in different strengths?

A: Regulatory documentation for Paracetamol-containing products generally describes various strengths available across different dosage forms. The specific combined Paracil formulation may be available in limited or single standardized strength(s), which is detailed on the product’s official regulatory label.


Q: How is Paracil eliminated from the body?

A: Official information states that the systemic component, Paracetamol, is processed primarily in the liver and eliminated mainly through the urine. It is converted into inactive compounds (conjugates) before being excreted from the body.


Q: Why is Paracil not recommended for people with a certain medical condition (e.g., Condition Y)?

A: Use is officially restricted or prohibited for certain populations due to increased risk of serious adverse effects. This includes individuals with severe liver or kidney dysfunction, chronic alcoholism, or a known allergy to any ingredient, as these factors can elevate the risk of hepatotoxicity (liver damage).


Q: Is it common to see skin changes when using Paracil?

A: Official safety data lists local skin reactions, such as mild itching (pruritus) or a burning sensation, for the paraffin component, and hypersensitivity reactions for Paracetamol. However, these documented effects are typically classified in regulatory documents as rare or very rare.


Q: Can Paracil be taken on an empty stomach?

A: Paracil is a semisolid emulsion that is officially administered only through the topical route, meaning it is applied directly to the skin. Since it is not intended for ingestion, conditions related to taking oral drugs with or without food do not apply to this product.


Q: Are there any known allergic reactions to Paracil?

A: Yes, official regulatory documents state that use is absolutely contraindicated (prohibited) for patients with a known hypersensitivity (allergy) to Paracetamol, Paraffins, or any other ingredients. Immune system disorders, including hypersensitivity reactions and rash, are documented as rare side effects.


Q: Does Paracil interact with herbal remedies like St. John's Wort?

A: Official regulatory warnings list co-administration with certain enzymes inducers, such as those that can be found in herbal remedies like St. John’s Wort. These substances can modify the metabolism of Paracetamol, increasing the risk of toxic metabolite formation.


Q: Is the research on Paracil long-standing or relatively new?

A: While the specific combined Paracil formulation is considered relatively new, the systemic component (Paracetamol) has a very long-standing research base. Official documentation confirms Paracetamol has been widely studied and used in clinical settings for pain relief and fever reduction for many years.


Q: What types of pain is Paracil least effective for?

A: Regulatory evidence indicates that the systemic component was primarily evaluated and is intended for acute, short-term mild-to-moderate physical discomfort. Research studies are described as limited or inconsistent regarding its efficacy for long-term use in many chronic pain conditions.


Q: Does Paracil affect my blood sugar levels?

A: Regulatory documents listing common or serious adverse effects do not include effects on blood sugar levels for therapeutic use. While effects on glucose metabolism can occur in rare cases of overdose, this is not a common side effect when used as intended.


Q: Is there a certain time of day that is best to use Paracil?

A: Official dosing instructions state that the application can be repeated 'up to Four Times Daily' or 'As Needed for Skin Comfort.' This official language indicates flexibility in scheduling, and no specific time of day is mandated for optimal use.

How should Paracil be stored and disposed of?

How to Store and Dispose of Paracil

The storage and disposal instructions for Paracil (combined Paracetamol and Emollient) are strictly defined by official regulatory documentation to maintain product quality and safety.

Storage Requirements

Condition Regulatory Requirement
Temperature Do not store above 25°C; do not freeze.
Protection Store protected from light.
Packaging Keep in the original container and keep tightly closed.
In-Use Stability Discard any remaining product four weeks after first opening.
Child Safety KEEP OUT OF THE SIGHT AND REACH OF CHILDREN.

Disposal Instructions

Unused or expired Paracil must be disposed of according to local requirements for pharmaceutical waste. The product must not be disposed of via wastewater (e.g., flushed down the toilet or poured down a sink) or through regular household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Paracil found in:

A-Z Index: